Your browser doesn't support javascript.
loading
Relative risk of tuberculosis in patients with rheumatic diseases managed with anti-tumour necrosis factor-alpha therapy: A nationwide cohort study.
Aydin, Volkan; Akici, Ahmet; Isli, Fatma; Aksoy, Mesil; Aydin, Mehtap; Gursoz, Hakki.
Afiliação
  • Aydin V; Department of Pharmacology, Marmara University School of Medicine, Istanbul, Turkey.
  • Akici A; Department of Pharmacology, Marmara University School of Medicine, Istanbul, Turkey.
  • Isli F; Turkish Medicines and Medical Devices Agency, Ministry of Health, Ankara, Turkey.
  • Aksoy M; Turkish Medicines and Medical Devices Agency, Ministry of Health, Ankara, Turkey.
  • Aydin M; Department of Infectious Diseases and Clinical Microbiology, Baskent University School of Medicine, Istanbul, Turkey.
  • Gursoz H; Turkish Medicines and Medical Devices Agency, Ministry of Health, Ankara, Turkey.
J Clin Pharm Ther ; 44(4): 553-560, 2019 Aug.
Article em En | MEDLINE | ID: mdl-30763469

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Doenças Reumáticas / Fator de Necrose Tumoral alfa / Antirreumáticos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Doenças Reumáticas / Fator de Necrose Tumoral alfa / Antirreumáticos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article